Date: 2016-04-26
Type of information: Resignation
Compound:
Company: Bionor Pharma (Norway)
Therapeutic area: Infectious diseases
Type agreement: resignation
Action mechanism:
Disease:
Details: * On April 26, 2016, Bionor Pharma announced that Dr. David Horn Solomon and Bionor’s Board of Directors have agreed that Dr. David Horn Solomon will leave his position as Chief Executive Officer of Bionor Pharma ASA, owing to a shareholder led change in company strategy. The Board of Directors will immediately initiate a search process for a new CEO. Until such search is concluded, the Board has appointed MSc Pharmacist Unni Hjelmaas as acting CEO.
Financial terms:
Latest news:
